Buyout Desk
Add-on

Nordic Capital-backed Inovalon to acquire DrFirst

DrFirst's medication management solutions are used by more than 670,000 providers, 71,000 pharmacies and over 2,000 hospitals in the U.S.

Target
DrFirst
Acquirer
Inovalon

Inovalon, a healthcare data and solutions provider whose lead investor is Nordic Capital, has signed a definitive agreement to acquire DrFirst, a prescription and clinical workflow technology company. The transaction is subject to required regulatory approvals and other customary closing conditions. The release gives no financial terms.

DrFirst was founded more than 25 years ago by James F. Chen, and its offerings include prescribing, prior authorization, benefit determination and patient communications. Inovalon CEO Adam Kansler said DrFirst's clinical-grade AI will extend Inovalon's reach to the point of care.

Citigroup Global Markets is exclusive financial adviser to DrFirst, with Skadden, Arps, Slate, Meagher & Flom as its legal counsel. Goldman Sachs is financial adviser to Nordic Capital and Inovalon, Kirkland & Ellis is legal counsel to Inovalon and Nordic Capital, and McDermott Will & Schulte is Inovalon's regulatory, privacy and healthcare legal counsel.

Background

Business
Prescription and clinical workflow technology company offering medication management, prior authorization and patient communication
Deal type
Add-on
Advisers
  • Citigroup Global Markets Inc. exclusive financial adviser to DrFirst
  • Skadden, Arps, Slate, Meagher & Flom LLP legal counsel to DrFirst
  • Goldman Sachs & Co. LLC financial adviser to Nordic Capital and Inovalon
  • Kirkland & Ellis LLP legal counsel to Inovalon and Nordic Capital
  • McDermott Will & Schulte regulatory, privacy and healthcare legal counsel to Inovalon

Sources

Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.

Nordic Capital deal history